Analysis of The Implementation of PSAK No. 71 on Impairment Loss Reserves: A Case Study of State-Owned Pharmaceutical Companies Listed on The Indonesia Stock Exchange (BEI)

Authors

  • Maya Sova University of Respati Indonesia, Jakarta, Indonesia
  • Thorman Lumbanraja University of Persada Indonesia Y.A.I., Jakarta, Indonesia
  • Muhammad Iqbal Ismail University of Persada Indonesia Y.A.I., Jakarta, Indonesia

DOI:

https://doi.org/10.38035/gijea.v1i2.42

Keywords:

PSAK No. 71, Impairment Loss Reserves, State Owned Pharmaceutical Companies, Indonesia Stock Exchange (BEI), Financial Reporting

Abstract

This study aims to analyze the implementation of Statement of Indonesia Financial Accounting Standards (PSAK) No. 71 regarding impairment loss reserves in state-owned pharmaceutical companies listed on the Indonesia Stock Exchange (BEI). PSAK No. 71 is a convergence of International Financial Reporting Standard (IFRS) 9 and provides guidelines for financial instruments. The research adopts a descriptive-analytical approach, utilizing data from financial statements and conducting interviews with relevant stakeholders. The qualitative analysis explores the application of PSAK No. 71 and evaluates the impairment loss reserves in these companies. The findings contribute to a better understanding of the implementation of PSAK No. 71 in state-owned pharmaceutical companies and its impact on financial reporting. The research also provides insights for companies, regulators, and supervisory authorities in the pharmaceutical sector regarding the application of PSAK No. 71.

References

Febriati, E. (2013). Analysis of the application of PSAK 55oon allowance for impairmenttlosses at PT Bank BRI. EMBA Journal 1(3), 2303-1174.
DSAK-IAI. (2019). Conclusion of Discussion Results of PSAK 71 Implementation Issues 2018 - 2019.
IASB. (2014). International Financial Reporting Standard No. 9 (IFRS 9): Financial Instruments.
Husni, Mohamad, Wenny Ariesta Apriliani, & Riyanthi Idayu. (2022). Analysis of the Implementation of PSAK 71 Related to Allowance for Impairment Losses (In State-Owned Banking Sector Companies Listed on the IDX). Journal of Valuation: Scientific Journal of Management Science and Entrepreneurship, Dep. Management, FEB, Bina Bangsa University Volume 2 Number 1 January 2022. Page 62-81.
Indonesia Stock Exchange. 2023. Financial & Annual Report. In www.idx.co.id. Accessed June 22, 2023.
Kieso, DE,,Weygandt, JJ, & Warfield,,TD (2011). IntermediateaAccounting (14th edition). Wiley.
PT Kimia Farma (Tbk.). (2020). Annual Report of PT Kimia Farma (Tbk.) 2020. www.kimiafarma.co.id.
PT Indofarma (Tbk.). (2020). Annual Report of PT Indofarma (Tbk.) 2020. www.indofarma.id.
PT Phapros (Tbk.). (2020). Annual Report of PT Phapros (Tbk.) 2020. www.phapros.co.id.
Smith, D. (2018). Accounting Decline: The Road to IFRS 9. Journal of Corporate Accounting & Finance, 29(2), 15-19.
Smith, A. (2018). Disclosure of impairment losses in the pharmaceutical sector. Journal of Accounting and Finance, 18(2), 51-63.
Sumarsan, Thomas..(2017). IndonesiannTaxation FifthhEdition. Jakarta: Index
Tuanakotta, TM. (2015). Audit. Jakarta: Salemba Empat.

Downloads

Published

2023-07-28

How to Cite

Sova, M. ., Lumbanraja, T. ., & Iqbal Ismail, M. (2023). Analysis of The Implementation of PSAK No. 71 on Impairment Loss Reserves: A Case Study of State-Owned Pharmaceutical Companies Listed on The Indonesia Stock Exchange (BEI). Greenation International Journal of Economics and Accounting, 1(2), 87–95. https://doi.org/10.38035/gijea.v1i2.42

Issue

Vol. 1 No. 2 (2023): (GIJEA) Greenation International Journal of Economics and Accounting (June 2023)

Section

Articles

License

Copyright :

Authors who publish their manuscripts in this journal agree to the following conditions:

  1. Copyright in each article belongs to the author.
  2. The author acknowledges that the GIJEA has the right to be the first to publish under a Creative Commons Attribution 4.0 International license (Attribution 4.0 International CC BY 4.0).
  3. Authors can submit articles separately, arrange the non-exclusive distribution of manuscripts that have been published in this journal to other versions (for example, sent to the author's institutional repository, publication in a book, etc.), by acknowledging that the manuscript has been published for the first time at GIJEA.